Meet ApplyKite Twin, the application assistant that learns with you
Meet your Twin, it learns with you
Your Twin learns with you
Launch week codes:30% off annual Pro20% off monthly Pro
Ends in00h00m00s
Ends in00h00m00s
Ute Jungwirth
5 days ago
Research Associate (Postdoctoral) in Cancer Drug Discovery and Target Validation Newcastle University in United Kingdom
Degree Level
Postdoc
Field of study
Biology
Funding
The position is part of an 18-month Cancer Research UK-funded project. It starts in January 2027 and is fixed-term until June 2028, with scope to extend. No salary or stipend amount is stated.
Deadline
Nov 20, 2026
Country
United Kingdom
University
Newcastle University
Apply for this position
Keywords
Suggested positions
About this position
Newcastle University’s Drug Discovery Group is recruiting a postdoctoral Research Associate to join Ute Jungwirth’s team within the Newcastle University Drug Discovery Group and Cancer Research Horizons Therapeutic Innovation environment.
The 18-month Cancer Research UK-funded project will validate emerging drug targets in squamous cancers. The work centres on understanding cancer cell signalling and generating the mechanistic and phenotypic evidence needed to assess whether potential targets can support future drug discovery decisions.
The successful researcher will use genetic manipulation approaches, including RNA interference, CRISPR and inducible degron systems, alongside cell-based and molecular assays. The role requires careful experimental judgement, critical interpretation of data and the ability to design robust assays that address both mechanism and phenotype.
The researcher will work in a multidisciplinary drug discovery team and collaborate with external partners. The project offers an environment connecting cancer biology, target validation and translational drug discovery, with prior experience in target validation—particularly in a drug discovery setting—providing a useful advantage.
Funding details
The position is part of an 18-month Cancer Research UK-funded project. It starts in January 2027 and is fixed-term until June 2028, with scope to extend. No salary or stipend amount is stated.
What's required
Applicants should have a strong background in cancer cell signalling and the experimental judgement to critically interpret data. Hands-on experience with genetic manipulation techniques, including RNAi, CRISPR, and inducible degron systems, is required. Applicants should be confident designing mechanistic and phenotypic assays, interested in how target validation informs drug discovery decisions, and enthusiastic about multidisciplinary teamwork with external collaborators. Previous target-validation experience, ideally in a drug discovery setting, is advantageous.
How to apply
Apply through the Newcastle University Research Assistant/Associate vacancy linked in the post. Review the vacancy details and submit the required application before 20 November 2026.
Make your next move.
Prepare your application
Review drafts and confirm requirements with the university.
Professors
Principal Investigator and Senior Lecturer/Associate Professor
United Kingdom
Research Interests
Tissue Engineering
Pharmacology
Tumor Microenvironment
Transdermal Drug Delivery
Cancer Biology
Make your next move.
Prepare your application
Review drafts and confirm requirements with the university.